CoChat

Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia

Open access

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Background There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrillary acidic protein (GFAP) is a measure of astrogliosis, a known pathological process of FTD, but has yet to be explored as potential biomarker. Methods Plasma GFAP and neurofilament light chain (NfL) concentration were measured in 469 individuals enrolled in the Genetic FTD Initiative: 114 C9orf72 expansion carriers (74 presymptomatic, 40 symptomatic), 119 GRN mutation carriers (88 presymptomatic, 31 symptomatic), 53 MAPT mutation carriers (34 presymptomatic, 19 symptomatic) and 183 non-carrier controls. Biomarker measures were compared between groups using linear regression models adjusted for age and sex with family membership included as random effect. Participants underwent standardised clinical assessments including the Mini-Mental State Examination (MMSE), Frontotemporal Lobar Degeneration-Clinical Dementia Rating scale and MRI. Spearman’s correlation coefficient was used to investigate the relationship of plasma GFAP to clinical and imaging measures. Results Plasma GFAP concentration was significantly increased in symptomatic GRN mutation carriers (adjusted mean difference from controls 192.3 pg/mL, 95% CI 126.5 to 445.6), but not in those with C9orf72 expansions (9.0, –61.3 to 54.6), MAPT mutations (12.7, –33.3 to 90.4) or the presymptomatic groups. GFAP concentration was significantly positively correlated with age in both controls and the majority of the disease groups, as well as with NfL concentration. In the presymptomatic period, higher GFAP concentrations were correlated with a lower cognitive score (MMSE) and lower brain volume, while in the symptomatic period, higher concentrations were associated with faster rates of atrophy in the temporal lobe. Conclusions Raised GFAP concentrations appear to be unique to GRN -related FTD, with levels potentially increasing just prior to symptom onset, suggesting that GFAP may be an important marker of proximity to onset, and helpful for forthcoming therapeutic prevention trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp-2019-321954

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 196

Metadata

Authors
Heller, C., Foiani, M. S., Moore, K., Convery, R., Bocchetta, M., Neason, M., Cash, D. M., Thomas, D., Greaves, C. V., Woollacott, I. O., Shafei, R., Van Swieten, J. C., Moreno, F., Sanchez-Valle, R., Borroni, B., Laforce Jr, R., Masellis, M., Tartaglia, M. C., Graff, C., Galimberti, D., Rowe, J. B., Finger, E., Synofzik, M., Vandenberghe, R., de Mendonca, A., Tagliavini, F., Santana, I., Ducharme, S., Butler, C. R., Gerhard, A., Levin, J., Danek, A., Frisoni, G., Sorbi, S., Otto, M., Heslegrave, A. J., Zetterberg, H., & Rohrer, J. D.
Affiliations
  • UK Dementia Research Institute (GB)
  • UCL Queen Square Institute of Neurology (GB)
  • University of Brescia (IT)
  • Sunnybrook Health Science Centre (CA)
  • University of Toronto (CA)
  • Karolinska University Hospital (SE)
  • University of Milan (IT)
  • University of Cambridge (GB)
  • Western University (CA)
  • German Center for Neurodegenerative Diseases (DE)
  • KU Leuven (BE)
  • Istituti di Ricovero e Cura a Carattere Scientifico (IT)
  • University of Coimbra (PT)
  • McGill University (CA)
  • University of Oxford (GB)
  • Ludwig-Maximilians-Universität München (DE)
  • Centro San Giovanni di Dio Fatebenefratelli (IT)
  • University of Florence (IT)
  • Universität Ulm (DE)
Corresponding author
Rohrer, Jonathan D
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2020-01-14
Volume
91
Issue
3
Pages
263-270
ISSN
  • 0022-3050 (ISSN-L)
  • 1468-330X
OpenAlex
W3000153083
Cited by
182
References
49
Citations by year
2026: 17 · 2025: 22 · 2024: 26 · 2023: 34 · 2022: 43 · 2021: 30 · 2020: 9
FWCI
12.56
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, cc-by)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by)
  • Lirias (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
  • Florence Research (University of Florence) (submittedVersion)
  • Scholarship@Western (Western University) (submittedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • DZNE Pub (submittedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Apollo
Funders
  • Bluefield project
  • Weston Brain Institute
  • ZonMw Memorabel (Deltaplan Dementie, project number 733 051 042)
  • Medical Research Council (MR/M008525/1, MR/M018288/1, MR/M023664/1)
  • Netherlands Organization for Scientific Research (HCMI 056-13-018)
  • Alzheimer Nederland
  • Brain Research Trust
  • Alzheimer's Research UK (ARUK-CRF2017B-2)
  • Stockholm County Council ALF
  • Wolfson Foundation (Leonard Wolfson Experimental Neurology Centre)
  • Association for Frontotemporal Degeneration
  • Hjärnfonden
  • National Institute for Health Research (BRC149/NS/MH, Cambridge Biomedical Research Centre, Queen Square Dementia Biomedical Research Unit, UCL/H Biomedical Research Centre)
  • Wallenberg Academy (Wallenberg Academy fellowship)
  • Swedish FTD Initiative-Schörling Foundation
  • Bundesministerium für Bildung und Forschung (FTLDc)
  • EU Joint Programme - Neurodegenerative Disease Research (2018-02754, Prefrontals VR Dnr 529-2014-7504, VR: 2015-02926)
  • Alzheimer Foundation
  • Italian Ministry of Health ((PreFrontALS) grant 733051042, Centres of Excellence in Neurodegeneration grant)
  • Institute of Neurosciences, Mental Health and Addiction (327387, Canadian Institutes of Health Research operating g, Centres of Excellence in Neurodegeneration grant)
  • Ontario Brain Institute
  • Mady Browaeys Fund (Research into Frontotemporal Dementia)
  • Association for Frontemporal Dementias Research (Association for Frontemporal Dementias Research Gr)
  • Dioraphte Foundation (09-02-03-00)
  • Center for Networked Biomedical Research on Neurodegenerative Disease
  • Wellcome Trust (103838, Multi-User Equipment Grant)
  • Tau Consortium
  • UK Dementia Research Institute UCL
  • Alzheimer's Society (AS-PG-16-007, PhD studentship)
  • Fundació Marató de TV3 (20143810)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
glial fibrillary acidic protein, progranulin, frontotemporal dementia, plasma biomarkers, neurofilament light chain, C9orf72 expansion, MAPT mutations, presymptomatic disease, astrocyte activation, temporal lobe atrophy, disease onset prediction, neurodegeneration
MeSH terms
C9orf72 Protein, Progranulins, Adult, Aged, Female, Glial Fibrillary Acidic Protein, Humans, Male, Middle Aged, Mutation, Biomarkers, Case-Control Studies, tau Proteins, Neurofilament Proteins, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. https://app.cochat.ai/papers/10.1136/jnnp-2019-321954
The paper
Heller, C., Foiani, M. S., Moore, K., Convery, R., Bocchetta, M., Neason, M., Cash, D. M., Thomas, D., Greaves, C. V., Woollacott, I. O., Shafei, R., Van Swieten, J. C., Moreno, F., Sanchez-Valle, R., Borroni, B., Laforce Jr, R., Masellis, M., Tartaglia, M. C., Graff, C., . . . Rohrer, J. D. (2020). Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2019-321954

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.